Stay updated on Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial
Sign up to get notified when there's something new on the Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial page.

Latest updates to the Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedA new page revision tag v3.4.2 was added, and the prior government funding lapse notice and revision v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the page version to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded a glossary toggle and minor text updates (capitalization and revision number) without changing any study data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedA new revision label v3.3.4 is now shown, replacing v3.3.3. This appears to be a minor metadata update with no visible changes to the study details.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page adds a consolidated 'Locations' section listing states (Arizona, Louisiana, Nevada, New Jersey, Texas, Washington) and removes the separate 'Arizona Locations', 'Louisiana Locations', etc., sections.SummaryDifference0.8%

- Check92 days agoChange DetectedThe change adds a new footer revision label 'Revision: v3.3.2' and removes 'Revision: v3.2.0'. This is a minor metadata update that does not affect study content or functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus Plus FOLFOX & BEV in CRC Clinical Trial page.